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It is currently thought that accessory cell function by monocyte/macrophage 
lineage cells is dependent upon their expression of cell surface I region-associated 
(Ia) glycoprotein determinants  (reviewed in  1-4).  Extensive evidence exists to 
support the hypothesis that cell surface Ia antigens  may constitute a  major cell 
surface recognition  network that  regulates  the genetic control  of the  immune 
response (reviewed in  5-7).  Recent studies (8,  9) have demonstrated that these 
cell surface  Ia  glycoproteins can  be induced  on various populations  of normal 
murine  macrophages  by conditioned  supernatants  from  iectin-stimulated  lym- 
phocyte cultures.  Ia expression on normal cells was shown in these experiments 
to be a transient event dependent upon the positive modulation of an undefined 
lymphokine activity in the crude supernatant preparations.  Negative modulation 
of Ia expression has also been demonstrated by prostaglandins (10). 
More recently,  work from  this  laboratory and  others  (11,  12) demonstrates 
that conditioned medium from concanavalin A (Con A)l-activated mouse or rat 
spleen cell cultures could stimulate the cell surface expression of Ia determinants 
on the murine macrophage cell lines WEHI-3 and P388DI. Subsequent experi- 
ments by other workers using these same macrophage cell lines as targets for Ia 
induction  suggest  that  the  active  Ia-inducing  component  of the  crude  Con  A 
supernatants is interferon-gamma  (INF-3') (13,  14), and they clearly show that a 
cloned  source  of murine  IFN-3,  will  stimulate  Ia  antigen  expression  on  the 
macrophage cell line WEHI-3 (15). 
In  this  report  we demonstrate  that  cloned murine  IFN-3, and  the active  Ia- 
stimulating  modality of conditioned  medium  from  Con  A-activated  rat  spleen 
cell cultures both stimulate the macrophage tumor cell line P-388D1  to release 
a second activity which, in turn,  is capable of inducing cell surface Ia expression 
on  the  monocyte tumor  cell  line  WEHI-3.  Experimental  evidence is  given  to 
demonstrate  that  this  Ia-inducing  factor  (IaIF)  is  neither  shed  cell  surface  Ia 
X  Abbreviations used in  this paper:  Con A, concanavalin A; FBS, fetal bovine serum; FC, flow 
cytometry; FITC, fluorescein isothiocyanate; IaIF, Ia-inducing factor; IFN-3,, interferon-gamma; 
MAb, monoclonal antibody; MN, mean fluorescence channel number; PAB, phosphate-buffered 
solution containing bovine serum albumin and sodium azide; PAH, polyacrylic  hydrazide-agarose; 
PBS, phosphate-buffered  saline. 
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antigens nor any known form of murine interferon.  The results clearly suggest 
that  immune  interferon  may  regulate  Ia  induction  by  the  stimulation  of the 
biosynthesis and/or release of IaIF that subsequently modulates both the quali- 
tative and quantitative expression of cell surface Ia antigens. 
Materials and  Methods 
Celt Lines.  The murine monocyte/macrophage lineage tumor cell lines P-388D 1 (16) 
and WEHI-3 (17) were maintained in RPMI 1640 supplemented with antibiotics and 10% 
fetal calf serum. This was the standard culture medium used in all experiments. These 
mononuclear  phagocyte  tumor  cell  lines  are  of  the  H-2  d  haplotype  and  have  been 
maintained in our laboratory in continuous culture for several years. 
Murine IFN-'y and Rat Con A Supernatant,  Spleen cell-derived conditioned medium was 
obtained by treating rat spleen cell suspension cultures for 48 h with Con A (5 t~g/ml), as 
previously described (18). The Con A-induced supernatant was diluted to 25 % concentra- 
tion in fresh medium before being used in the WEHI-3 induction cultures. Cloned murine 
IFN-3, was provided by Dr. Patrick Gray, Genentech, Inc., South San Francisco, CA. The 
cloned IFN-'r was produced by transfecting the monkey cell line COS-7 with the probe 
specific for the DNA sequence coding for murine IFN-3,. The experimental details of the 
cloning procedures are described elsewhere (19). Negative control supernatants consisted 
of conditioned medium from normal COS-7 cultures. 
Production oflalF.  IaIF was obtained from  10-ml P-388D1  suspension cultures that 
were  initially  seeded  at  2.5  ×  105  cells/ml  and  treated  with  either  25%  rat  Con  A 
supernatant  (vol/vol) or  50  U/ml  of cloned  murine  IFN-3,.  Induction  cultures  were 
incubated at 7%  CO~ for 48 h.  Cells were then centrifuged at 200 g, washed twice in 
sterile  culture  medium, and  reseeded at  2-5  ×  105  cells/ml in  fresh culture  medium 
containing no exogeneous source of murine immune interferon for an additional 24 h. 
Cells were centrifuged at 200 g and the conditioned medium was collected and stored at 
4 °C. This was the source of IaIF in all experiments. 
la Induction Assay.  WEHI-3 was used as the target cell to assay the Ia-inducing activity 
of the following: (a) cloned murine IFN-3,, (b) the rat Con A  supernatant or, (c) the P- 
388Dl-derived  IaIF. WEHI-3 was seeded at  1  ×  10S/ml in  10-ml suspension cultures 
containing either 50 U/ml of the cloned murine IFN-3,, 25% (vol/vol) of Con A super- 
natant,  or 25%  (vol/vol) of the  P-388Dl-derived  IaIF supernatant.  The cultures  were 
incubated for 48 h at 7% CO2 and the cells were then centrifuged at 200 g, washed twice 
in  calcium- and  magnesium-free 0.01  M  phosphate-buffered solution  containing  0.1% 
bovine serum albumin and 0.1% sodium azide (PAB), and stained with appropriate anti- 
Ia  d monoclonal antibodies (MAb) for flow cytometry (FC) analysis. 
It is important to note that both macrophage tumor cell lines are capable of releasing 
IaIF under active stimulation by an interferon source, and both cell lines can effectively 
be used as targets in the Ia induction assay using IaIF supernatant from either P-388D1 
or WEHI-3 (unpublished results). We elected to use P-388D1  as the "producer" cell line 
and WEHI-3 as the target because the observed levels of background staining with the 
anti-Ia MAb on uninduced P-388D1 due to Fc receptor binding and constitutive expres- 
sion  of cell  surface  Ia were  significantly  higher  than  on  WEHI-3.  Additionally,  on  a 
comparative basis, P-388D 1 cultures generated almost five- to eightfold more IaIF activity 
(on a per cell basis) than WEHI-3. 
MAb/Fluorescent Reagents.  The two anti-Ia  d MAb used in the assay were MK-D6 (anti- 
I-Ad), developed by Dr.  P.  Marrack and  Dr. J.  Kappler (20), and an anti-I-E/C  d'k (anti- 
Ia.7) MAb probe,  clone  13/18,  developed by Dr.  G.  Hammerling (21).  The anti-I-A  k 
MAb, clone 10-3.6, was developed in the laboratory of Dr. Leonard Herzenberg (22) and 
was  generously  provided  to  us  for  this  study.  The  MK-D6  and  anti-Ia.7  MAb  were 
obtained from the Becton-Dickenson Monoclonal Antibody Center, Inc., Mountain View, 
CA.  All  fluorescence  staining  was carried  out  using  an  indirect  immunofluorescence 
procedure. The "second-step" antisera was a fluorescein isothiocyanate (FITC)-conjugated 1534  MECHANISM  OF  INTERFERON-3,  REGULATION OF  Ia  INDUCTION 
(fluorescein/protein ratio of 6.24), affinity-purified, goat anti-mouse IgG heteroantiserum 
(No. 6250; Tago, Inc., Burlingame, CA). 
Immunofluorescent Staining.  WEHI-3 target cells (5 ×  105 in 50/LI) were aliquoted into 
10 ×  75-mm borosilicate glass tubes. Four separate samples were aliquoted from each test 
culture  and  stained  in  the  following  manner:  (a)  The  first  sample  tube  received  no 
antibody treatment and was analyzed to determine background autofluorescence. (b) The 
second FC sample tube was first stained with a saturating concentration of the inappro- 
priate anti-I-A  k (3,2a) MAb,  followed by staining with  the  FITC-conjugated goat anti- 
mouse IgG antiserum. This sample served as the "negative control" since any antibody 
binding was due to nonspecific Fc receptor binding of the inappropriate anti-I-A  k MAb 
that has the same ~,2a heavy chain isotype as the anti-Ia  d MAb. (c) The last two sample 
tubes in each test group were stained with saturating concentrations of either MK-D6 or 
anti-Ia.7 MAb, respectively, followed by staining with the FITC-conjugated goat antiserum 
(as  above).  Positive fluorescence  emission  from these  samples represented  staining  of 
either I-A  d or I-E/C  d determinants. All antibody incubations were carried out at 4°C for 
30 min and cells were washed twice in PAB after each antibody incubation. 
FC Analysis.  FC  analysis was  performed  using  either a  FACS  III instrument  (B-D 
FACS  Systems,  Mountain  View,  CA)  or  the  FC  systems at  the  Los  Alamos National 
Laboratory (LANL), Los Alamos, New Mexico. The details of FC analysis using the FACS 
III (23) and the  LANL system (24)  have been described previously. It is important to 
note that the fluorescence staining profiles of a given cell sample are displayed on the 
FACS III instrument on a linear scale of 256 channels (fluorescence intensity increasing 
from left to right), whereas the fluorescence emission on the LANL instrument is recorded 
over a  255  channel,  3  decade  log scale (fluorescence  intensity increasing from left to 
right). The raw data from all test samples is gated to eliminate either dead or aggregated 
cells from analysis as described previously (24).  The negative control for each test sample 
consists  of cells  stained  with  the  inappropriate  anti-I-A  k ('r2a)  MAb  and  the  FITC- 
conjugated  second  antibody.  Data  is  presented  in  two  ways:  (a)  as  the  percentage of 
positive cells  in  each  test  sample  minus  the  percentage  of positive cells  (background 
staining) in the negative control, and (b) as the difference between the mean fluorescence 
intensity (mean fluorescence channel number) of cells stained with either of the two anti- 
Iad MAb and the FITC-conjugated antibody and cells stained with the anti-I-A  k MAb and 
the FITC-coupled second antibody. The mean fluorescence channel number (MN) indi- 
cates the degree to which a given population of cells are positive for a given Ia antigen. 
Interferon Assay.  Interferon was assayed by a modification of the plaque reduction assay 
of McGhee et al.  (25).  Briefly, mouse L-929  cells  were grown in  modified Ham's F12 
medium supplemented with  10% fetal bovine serum (FBS). Serial twofold dilutions were 
made of each unknown sample in medium supplemented with 5% FBS.  One ml of each 
dilution was added to confluent monolayers of L cells in 25-mm  ~  wide-mouth tissue culture 
flasks.  Each dilution was inoculated into replicate flasks.  The flasks were incubated for 24 
h at 37°C at 5% CO2. The sample dilutions were removed and the flasks were rinsed with 
Hank's balanced salt solution.  The cells were challenged with vesicular stomatitis virus 
(Indiana strain) which was allowed to adsorb for 1 h. Monolayers were overlayed with 5 
ml  of medium  containing  5%  FBS  and  0.4%  agarose and  again  incubated  for  24  h. 
Monolayers were  then  fixed  in  10%  formalin  in  phosphate-buffered saline  (PBS)  and 
stained  with  0.25%  crystal  violet  and  the  number  of plaques  was  determined.  The 
interferon  titer was defined as the  reciprocal of the  dilution  of unknown  sample that 
reduced the number of viral plaques by 50% from that observed in untreated cultures. 
Protein A  Column.  Staphylococcal protein  A,  covalently linked to  Sepharose CL-4B 
(protein A-Sepharose) was purchased from Pharmacia Fine Chemicals, Uppsala, Sweden. 
The protein A-Sepharose was swollen in  10 mM PBS,  pH 8.0, containing 0.1% sodium 
azide and was packed (5-ml bed volume) in a 10-m) plastic pipette. The elution buffer was 
3  M  sodium thiocyanate (NaSCN) and the elution  procedure was as described for the 
specific elution  of murine  3,2  immunoglobulin  (26).  The selective binding  of murine 
immunoglobulin isotypes to protein A-Sepharose is well-characterized (27) and the pro- WALKER ET  AL.  1535 
cedure has been used extensively in this laboratory for the purification of isotype-specific 
murine immunoglobulins. 
Affinity Column.  Affinity-purified MK-D6 (~'2a) and Leu-1 (3,2a) monoclonal antibodies 
(Becton-Dickenson Monoclonal Antibody Center,  Inc.) were chemically lii~ked  to poly- 
acrylic hydrazide-agarose (PAH) (Miles Scientific, Naperville, IL) by a sodium borohydride 
procedure as described (28). Two mg of purified antibody was coupled to  1 ml (packed 
volume) of PAH for each of the two columns. After washing the columns with 0.01  M 
PBS to remove azide, the  2.5-ml test samples were applied and mixed with the column 
bed to form a  slurry. The column was allowed to settle by gravity at room temperature 
for 5 min before elution.  The sample was eluted at a  flow rate of 0.5 ml/min; after the 
initial sample was below the level of the gel bed, a final 6-7 ml of fresh culture medium 
was washed over the column and collected in the sample tube. 
Anti-lFN-'y-blocking  Antibody.  The anti-murine  IFN-q,-blocking antibody used  was a 
rabbit  anti-IFN-3,  IgG raised  by repeated  subcutaneous  immunization  with  a  partially 
purified  (sp act >  10  s #m/mg of protein),  phytohemagglutinin-induced  murine  spleen 
cell-derived IFN-3'. The anti-IFN-y heteroantiserum had a neutralizing titer of 5,000 U/ 
ml (defined as the reciprocal of the highest antiserum  dilution that neutralized  10 U  of 
murine IFN-~,). The antiserum was purchased from Enzo Biochem, Inc., New York (cat. 
No. EAB-473, lot No. 2/09/001). 
Results 
FC Analysis of la Induction of WEHI-3 ~  Cloned IFN-%  Rat Con A Supernatant, 
and P-388Dl-derived  lalF.  Fig. 1 gives a summary of typical experimental results 
using  indirect  immunofluorescence  and  quantitative  FC  analysis  to  examine 
WEHI-3  cells for the expression  of Ia cell  surface  antigens after  incubation in 
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FIGURE  1.  Overlays of gated fluorescence  histograms  for WEHI-3 cells stained with MK-D6 
(anti-I-A d) MAb followed by FITC-conjugated goat anti-mouse  IgG compared with the same 
test sample stained  with an inappropriate anti-I-A  k MAb (10-3.6) and FITC-conjugated goat 
anti-mouse  IgG antiserum.  The test groups are made up of 5 x  105 WEHI-3 target cells taken 
from suspension  cultures grown in: (A) medium only [RPMI 1640 (10% FCS)], (B) medium 
plus 50 U/ml of cloned murine IFN-'t, (C) 25% (vol/vol) rat Con A supernatant, (D) medium 
p]us 25%  (vol/vol) of P-388Dl-conditioned medium, (E) medium plus  25% (vol/vol) of P- 
388Dl-generated IaIF (after  activation  by 50 U/ml of cloned routine IFN--t). Analysis was 
carried out on the Becton-Dickenson  FACS Ill. The x axis indicates a  2.56 channel linear 
scale, increasing fluorescence intensity left to right; y axis indicates the number of cells in each 
channel. Voltage and gain settings on the fluorescence amplifier were the same for all samples. 
10,000 cells were analyzed for each test sample. 1536  MECHANISM  OF  INTERFERON-~,  REGULATION  OF  Ia  INDUCTION 
either medium alone (Fig.  1A),  50  U/ml of cloned IFN-~" (Fig.  1B),  25%  (vol/ 
vol) rat Con A  supernatant (Fig.  1 C),  25%  (vol/vol) P-388Dl-conditioned me- 
dium (Fig. 1 D), or 25% (vol/vol) IaIF supernatant derived from P-388D 1 cultures 
after the cells had been stimulated by murine IFN-~,  (Fig.  1 E). As displayed in 
Fig.  1,  WEHI-3  does  have  some  weak  background  expression  of 
I-A antigen;  however, after culture  in  rat  Con  A  supernatant  or the  cloned 
murine immune interferon, there is a profound increase in fluorescence due to 
the increased expression of cell surface I-A determinants. Fig.  1 D clearly shows 
that conditioned medium taken from P-388D1  before stimulating the macro- 
phage cell line with an exogenous source of IFN-~ had no effect in inducing the 
expression of cell surface Ia antigens on WEHI-3 target cells. By contrast, WEHI- 
3  target cells cultured in  IaIF supernatant taken from P-388D1  cells that had 
been initially activated by a  48-h  preincubation in cloned murine IFN-3,  (Fig. 
1 E) were again strongly induced for the expression of I-A antigens. Thus, rat 
Con  A  supernatant,  cloned  murine  IFN-7,  and  supernatant  taken  from  the 
macrophage tumor  cell  line  P-388D1  after  its  activation  by  cloned  immune 
interferon stimulate quantitatively significant increases in the expression of cell 
surface Ia antigens on the macrophage tumor cell target WEHI-3.  The data in 
Table I show that there is an increase in the cell surface expression of the I-E/C 
TABLE  I 
FC Analysis of la Induction of WEHI-3 by Cloned IFN-'y, Rat Con A 
Supernatant,  and P-388D l-derived lalF 
Percent 
WEHI-3 test culture  MAb  AMN*  positive 
cells* 
Culture medium  MK-D6  11  13 
Ia.7  I t  I0 
Rat Con A supernatant (25%)  MK-D6  110  94 
Ia.7  108  92 
IFN-'y (50 U/ml)  MK-D6  106  96 
Ia.7  103  95 
Control P-388Dl-conditioned medium  MK-D6  5  8 
la.7  6  10 
IaIF (IFN-7 induced)  MK-D6  80  86 
la.7  67  79 
* AMN  values indicate the difference in the mean channel fluorescence (on a 
linear scale)  between a gated population of WEHI-3 target cells stained with 
an  inappropriate anti-I-A  k (~,2a) MAb and the enhancing, FITC-conjugated 
goat anti-mouse second antibody and a sample stained with either the anti-I-A  d 
(MK-D6) or the anti-I-E/C  ° (Ia.7) MAb and theFITC-labeled goat anti-mouse 
second antibody. Fluorescence was measured on the 256 channel linear fluo- 
rescence scale of the Becton-Dickenson FACS III;  10,000 cells were analyzed 
per sample. 
at The percent positive cells for each test culture indicates the difference  between 
the percentage of cells that stain for positive fluorescence with the anti-I-A  t 
(negative control) MAb and the percentage of the test sample that stained by 
the MK-D6 or Ia.7 MAb. The negative control sample from the medium-only 
test culture was gated such that ~ 10% of the stained cells showed fluorescence 
emission brighter than the channel number selected as the lower fluorescence 
window. This channel number was used as the lower limit of positive fluores- 
cence for all test samples. WALKER  ET  AL.  1537 
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FIGURE 2.  WEHI-3 was grown in 25% (vol/vol) rat Con A supernatant alone (A), 25% (vol/ 
vol) rat  Con A  supernatant  preincubated  with a  5,000  U  equivalence of anti-murine IFN-~' 
heteroantiserum  (B), 25%  (vol/vol) P-388Dl-derived  IaIF (C), 25%  (vol/vol) of P-388D1- 
derived IaIF preincubated with a  5,000  U  equivalence of an anti-murine IFN-3,  heteroantis- 
erum (D). All the laIF supernatants were harvested from P-388DI  cultures initially activated 
with  50  U/ml  of cloned  murine  IFN-3,.  Overlays demonstrate  a  comparison  of staining 
histograms for MK-D6 (LA  d) MAb staining to those of WEH1-3 cells stained with an inappro- 
priate anti-I-A  ~ MAb 00-3.6)  and  FITC-conjugated goat anti-mouse  IgG second antibody. 
10,000 cells were analyzed per test sample on the Becton-Dickenson FACS III. Raw histograms 
were gated to eliminate dead and aggregated cells. X axis indicates a 256 channel linear scale 
of increasing fluorescence emission from left to right; y axis indicates the number of collected 
cells in each fluorescence channel. 
antigen  density  comparable  to  that  observed  for  the  I-A  determinant  after 
treating  WEHI-3  with  cloned  immune  interferon,  rat  Con  A  supernatant,  or 
IaIF derived from  IFN-3,-activated  P-388D1  cells.  Thus,  there was a  quantita- 
tively similar increase in both the amount of anti-Ia staining, as measured by the 
increase in MN, and the present positive cells for the I-A (MK-D6), and the I-E/ 
C  (Ia.7)  antigens  after  the  target  cells  are  activated  by any  of the  three  Ia 
induction regimens. 
Anti-murine  IFN-3,-blocking Experiments.  Since  IaIF  was  collected  from  P- 
388D1  supernatants after cellular activation by either rat Con A supernatant or 
cloned murine interferon, it was important to show that the Ia induction observed 
after treatment  of WEHI-3 targets  by IaIF was not due simply to carryover of 
IFN-T that  might have adhered to the P-388D1  cells when they were removed 
from the initial activation cultures. Additionally, although macrophages are not 
commonly thought to release IFN-3,, it was important to eliminate the possibility 
that P-388D1  could be mediating Ia-inducing function via the release of endog- 
enously generated  immune  interferon.  Thus  2.5  ml of rat  Con A  supernatant 
was incubated (12 h, 4°C) with a 5,000 U equivalence of an anti-murine  IFN-3,- 
specific  heteroantiserum.  The  antibody-treated  rat  Con  A  supernatant  was 
subsequently added at  25% (vol/vol) to a  10-ml culture of WEHI-3 cells.  Our 
analysis of the interferon concentration of the crude rat Con A supernatant (see 1538  MECHANISM  OF  INTERFERON-3'  REGULATION  OF  la  INDUCTION 
below) indicated it had ~25-30  U/ml of activity. In a similar fashion, 2.5 ml of 
P-388Dl-derived IaIF was also preincubated with a 5,000  U equivalence of the 
same anti-IFN-7  heteroantibody before its addition to  the WEHI-3  induction 
culture (25%  vol/vol).  Fig.  2 shows the results of a representative experiment. 
WEHI-3 in 25% rat Con A supernatant showed a positive fluorescence shift for 
the I-A  a marker, MK-D6 (Fig. 2A). Preincubation of the rat Con A supernatant 
before use in the induction culture completely blocked the Ia induction response 
on WEHI-3, as observed in panel Fig. 2B.  Identical results were obtained using 
cloned murine IFN-7 (Table II) and the same anti-murine IFN-3, antiserum. In 
contrast, the Ia-inducing effects of P-388Dl-derived IaIF were essentially unaf- 
fected by any attempt to block them with preincubation of the active supernatant 
with the anti-murine interferon antiserum. Thus, anti-I-A  a fluorescence staining 
produced a strong positive shift in immunofluorescence for cells cultured with 
IaIF in the absence of any anti-IFN-'r-blocking regimen (Fig. 2 C) and a quanti- 
tatively comparable positive shift in anti-I-A  a fluorescent staining for cells cul- 
tured in IaIF that was pretreated with the blocking antibody (Fig. 2D). Table II 
gives the values for the mean channel fluorescence differences (AMN) and the 
differences in the percent of positive cells between the negative control sample 
and the anti-I-A  a- and anti-I-E/Ca-stained samples from each test culture in the 
experiment represented by the FC histograms in Fig.  2.  The data in Table II 
shows that the immunofluorescence staining profile for I-E/C  a determinants is 
the same as that for the anti-I-A  a fluorescent staining shown of Fig. 2. This data 
clearly suggests that, although the Ia-inducing activity of rat Con A supernatant 
and purified (cloned) murine IFN-7 can be totally abrogated by an anti-IFN-3' 
antiserum,  the  Ia-inducing activity demonstrated by  P-388Dl-derived  IaIF  is 
essentially unaffected by the same blocking regimen. 
Antivirat Activity, ofP-388Dl-derived lalF.  Although macrophage are not corn- 
TABLE  II 
FC Analysis of the Effects of Anti-IFN-3, Heteroantibody on the la-inductive 
Capacity of Rat Con A Supernatant,  Cloned Murine IFN-7, and lalF 
Percent 
WEHI-3 test culture  MAb  AMN*  positive 
cells* 
Medium control  MK-D6  10  <5 
Ia.7  8  <5 
Rat Con A supernatant (25% vol/vol)  MK-D6  68  85 
Ia.7  64  81 
Rat Con A supernatant (25% vol/vol)  MK-D6  6  10 
(treated with anti-IFN-3, Ab)  Ia.7  5  8 
IFN-7 (50 U/ml)  MK-D6  80  90 
Ia.7  74  87 
I FN-3, (50 U/ml) (treated with anti-  M K-D6  7  12 
IFN--~ Ab)  la.7  8  10 
IalF  MK-D6  45  59 
Ia,7  46  69 
lalF (treated with anti-IFN-'r Ab)  MK-D6  40  59 
Ia.7  41  57 
*'* See legend to Table I. WALKER  ET  AL.  1539 
monly known to produce immune interferon, they are known to generate and 
release  alpha  interferon  (reviewed  in  29).  It  was  of  interest,  therefore,  to 
determine if the IaIF activity observed in IFN-y-activated P-388D 1 supernatants 
was  attributable  to another  known  molecular  species of interferon.  This  was 
done in two ways. Indirectly, we evaluated the ability of purified alpha (a) and 
beta (/3) murine interferon to stimulate Ia expression, using up to 1,000 U/ml of 
either purified alpha or beta murine interferon (Lee Biomolecular, San Diego, 
CA) in the standard WEHI-3  induction system. As reported by others (29), we 
observed no quantitatively significant increase in Ia expression after culturing 
the target cells with these purified interferon species (data not shown). 
Using a  more direct  method of analysis,  we tested  IaIF active supernatants 
from IFN-y-activated P-388D 1 cultures for the presence of any antiviral activity. 
As described in Materials and Methods, the assay was carried out using a standard 
plaque  reduction  assay  (25)  using murine  L929  cells and  vesicular  stomatitis 
virus. Table III shows the data collected from two individual experiments. Cloned 
murine IFN-7 and rat Con A supernatant both showed quantitatively significant 
levels of antiviral  activity,  1,500  U/ml and  20-25  U/ml,  respectively.  The P- 
388Dl-derived  IaIF supernatant was negative for any antiviral activity (<1  U/ 
ml) in both experiments. Since an undiluted supernatant of IaIF showed virtually 
TABLE  III 
Comparative IFN Titers of Active la-inductive Supernatants 
I-A induction  Interferon con- 
WEHI-3 test culture  (AMN)*  centration 
Exp.  1  Exp. 2 
Medium alone  8  10 
Rat Con A supernatant  130  110 
Cloned murine IFN-~  136  NT  ! 
IaIF (P-388D1 derived)  110  86 
New Castle disease virus  !  NT  NT 
Exp.  1  Exp. 2 
U/ml* 
<1  <1 
25  22 
1,500  NT 
<1  <1 
NT  1,024 
* la induction activity was determined by using the standard Ia induction 
assay described in Materials and Methods.  Anti-I-A  d (MK-D6) fluores- 
cence was measured on the Los Alamos National Laboratory flow system 
and AMN values represent the differences in mean channel fluorescence 
on a log scale between a negative control sample of WEHI-3 target cells 
stained with the anti-I-A  k MAb (10-3.6) and FITC-conjugated second 
o  antibody and a  test sample of cells stained with the anti-I-A  (MK-D6) 
MAb and FITC-conjugated second antibody, la induction cultures were 
stimulated  with  25%  (vol/vol) rat  Con  A  supernatant,  25%  (vol/vol) 
IalF, and 50 U/ml IFN-% respectively. 
Interferon units are calculated as described in Materials and Methods. 
Units of activity in this assay only reflect the relative interferon activity 
of the various undiluted supernatants compared with each other in a 
single experiment, and do not represent units of activity calculated as a 
result of comparison with an international reference standard of inter- 
feron activity. Interferon data represent the average titer results from 
replicate flasks. 
m  New Castle disease virus was used to induce interferon in murine 3T3 
cells and this supernatant was the internal control in the second experi- 
ment. 
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no antiviral activity, but a  1:4 dilution of the same supernatant shows potent Ia- 
inducing activity, the results of the antiviral function experiments clearly suggest 
that the Ia-inducing activity of P-388D 1-generated supernatant is not due to any 
known species of murine interferon. 
Analysis  of P-388Dl-derived  IalF for  Shed Ia  Antigen  (MK-D6  Affinity  Col- 
umn).  Since the IFN-y- or rat Con A supernatant-activated  P-388D1 cells used 
as  the  source  of IaIF  are  highly  Ia  positive  before being  recultured  in  fresh 
medium  (12,  13),  we  carried  out  experiments  to  demonstrate  that  the  IaIF 
activity  was  not  simply attributable  to  shed  Ia  determinants  that  were  being 
transferred in culture to the WEHI-3 target cells. Table IV shows experimental 
results  obtained  when  we  attempted  to  test  the  ability  of an  anti-Ia  affinity 
column to deplete an IaIF-positive supernatant  of its Ia-inducing activity. 2 mg 
of affinity-purified MK-D6 (anti-LA d) MAb was coupled to 1 ml (packed volume) 
of PAH  (see  Materials  and  Methods).  We determined  from previous titration 
experiments  (data  not  shown)  that  2.5  ml  of IaIF  usually  provided  optimal 
induction  of up to  107 target  cells in a  standard  10-ml,  48-h induction  culture, 
and that 1.0 #1 (1 mg/ml) of purified anti-I-A d (MK-D6) MAb provided saturation 
binding for >107 WEHI-3 cells grown in such cultures.  Thus,  2 mg of MK-D6 
antibody represented a 2,000-fold antibody excess if one assumed that all the Ia- 
inducing  capacity of 2.5 ml of IaIF supernatant  was due to shed  Ia antigen.  A 
2.5-ml sample of IaIF was mixed in a slurry with the PAH column bed, allowed 
to settle by gravity, and incubated at room temperature for 5 min before being 
eluted off the column with 6.5 ml of fresh medium.  1 ml of FBS was added to 
the 9-ml eluent and the  10-ml sample was filter sterilized and added to WEHI-3 
cells seeded at  1 ×  105/ml.  After the standard  48-h incubation,  the target cells 
TABLE  IV 
Effect of Anti-l-A  Affini~, Column Passage on la-inductive Capacity of lalF 
Percent 
Test cultures  Antibody staining*  MN ~  positive 
cells  O 
WEHI-3 +  25% lalF  Negative control stain  30  -- 
MK-D6  98  54 
Ia.7  100  58 
WEHI-3 +  25% IaIF  Negative control stain  21  -- 
after MK-D6 affinity column passage  MK-D6  63  32 
Ia.7  74  52 
WEHI-3 +  25% laIF  Negative control stain  20  -- 
after Leu-1 affinity column passage  MK-D6  54  21 
Ia.7  78  49 
* Samples labeled with the anti-I-A  k MAb (10-3.6) and FITC-conjugated second antibody are the 
negative controls. Background fluorescence is due to nonspecific binding of the inappropriate anti- 
k  I-A  reagent to WEHI-3 target cells. 
* MN  values are  measured on  a  255  channel,  three  decade  log  fluorescence  scale  (Los  Alamos 
National Laboratory flow system) and represent the mean fluorescence due to binding of anti-Ia 
MAb and FITC-conjugated second antibody (see Materials and Methods for immunofluorescence 
staining procedure) by a  gated population of WEHI-3  target cells selected to exclude dead and 
aggregated cells. 
! See footnote * to Table I; percent positive cells equals the percent difference between the negative 
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were harvested  and  stained  for cell  surface  Ia  expression.  A  negative  control 
column  made  up  of coupled  Leu-1  MAb  (3'2a)  was  used  in  exactly  the  same 
fashion  and  the  eluent  from  this  column  passage  was  similarly  tested  for  Ia- 
inducing capacity.  As Table  IV shows, there is a quantitatively  significant dimi- 
nution of the ability of an active IaIF sample to induce I-A  a expression on WEHI- 
3 after passage over the MK-D6 affinity column. However, there is a comparable 
loss of I-A a induction  potential  of the same  IaIF supernatant  after its passage 
over the Leu-1  affinity column.  The quantitatively  similar loss of activity after 
passage on the negative control column clearly suggests that the abrogation of I- 
Aa-inductive capacity observed after passage over either column was due to some 
form of nonspecific binding of the active component. Additionally, IaIF samples 
passed over either column showed a quantitatively similar loss of I-E/Ca-inductive 
capacity,  as  demonstrated  by  the  comparable  loss  of MN  and  the  percent  of 
positive cells due to anti-Ia.7 MAb staining in the two test cultures, as compared 
to the anti-Ia.7 staining profile for WEHI-3 cells cultured with unprocessed IaIF. 
Again,  this  clearly  suggests  that  any  observed  loss  of  Ia-inductive  potential 
subsequent  to  column  passage  of  IaIF  is  directly  attributable  to  nonspecific 
binding of the active factor to the columns, and is not due to specific binding of 
the column-complexed  anti-Ia antibody to the appropriate molecular species of 
shed  Ia  antigen.  After  the  nonspecific  loss  of activity  due  to  MK-D6  affinity 
column passage, there is still a quantitatively significant amount of I-A induction 
activity in the eluent, as shown by a AMN of a 42 channel shift (log scale) between 
the negative control sample and the sample stained with the anti-I-A  a MAb. 
Analysis of P-388D l-derived  lalF for Shed la  Antigen (Protein A-Sepharose Col- 
TABLE  V 
Effects of Incubation with an Anti-I-E/C ~ MAb and Protein A-Sepharose Column Passage on the 
Ia-inductive Capacity of lalF 
Percent 
WEHI-3 test culture  Antibody staining*  MN*  positive 
cells  ! 
WEHI-3 in medium alone  Negative control stain  38  -- 
MK-D6 (>I-A  d)  34  0 
Ia.7 (>I-E/C d'k)  33  0 
¢¢EHI-3 +  25% IaIF  Negative control stain  34  -- 
MK-D6 (>I-A  a)  76  78 
Ia.7 (>I-E/C a'k)  69  72 
WEHI-3 +  25% preincubated column-  Negative control stain  39  -- 
passed IaIF  MK-D6 (>FA d)  79  60 
Ia.7 (>I-E/C a'k)  76  58 
,  k  Anti-I-A  (10-3.6)  MAb and FITC-goat  anti-mouse IgG antibody labeling is used as the negative 
k  control stain and measures only nonspecific binding of the inappropriate anti-I-A  (72a) antibody 
and the  fluoresceinated,  enhancing  second  antibody  to  the  target  cells.  MK-D6  and  Ia.7  MAb 
fluorescence are compared with the negative control sample and show the increase in fluorescence 
staining due to increased cell surface Ia expression. 
* MN values are measured on a 256 channel linear fluorescence scale of the Becton-Dickenson FACS 
III  and represent  the mean fluorescence  emission for all the cells within a  gated  population of 
WEHI-3 targets from which dead and aggregated  cells are excluded. Increases in MN values over 
the negative control sample indicate an increase in cell surface Ia antigen expression. 
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umn).  As a result of the high degree of nonspecific binding of the IaIF activity 
to the antibody-coupled PAH columns, we carried out a second control experi- 
ment to test for the presence of shed Ia antigens in IaIF supernatant. 2.5 ml of 
active IaIF supernatant from P-388D1  was preincubated with 200/A (1  mg/ml) 
of affinity-purified anti-Ia.7 (I-E/C) MAb (12 h, 4°C). By calculations similar to 
those previously described (see above), 200 #1 of affinity-purified anti-Ia.7 MAb 
represents a 200-fold neutralizing excess of antibody if the Ia-inducing capacity 
of 2.5  ml of IaIF is simply due to shed Ia molecules. The 2.5  ml of anti-Ia.7 
MAb-treated  IaIF  was  poured  over  a  5-ml  protein  A-Sepharose  4B  column 
(binding capacity,  100  mg protein) and eluted slowly (0.5 ml/min) with 6.5  ml 
of fresh medium.  1 ml of fetal calf serum was added to the eluent and it was 
filter sterilized before being added to a standard WEHI-3 Ia induction culture. 
The data in Table V show the MN values and the percent of Ia-positive cells for 
gated populations of WEHI-3 tumor target cells grown in 25% IaIF before and 
after the supernatant was treated with anti-Ia.7 MAb and passed over the protein 
A-Sepharose column. The data show that there was only marginal loss of I-A  d 
determinant induction activity in the column-passed material compared with the 
untreated sample of IaIF as measured by the percentage of I-Ad-positive cells in 
the two cultures. I-E/C induction activity was also relatively undiminished in the 
anti-Ia.7-treated, column-passed sample of IaIF. These results strongly suggest 
that the Ia-inducing activity of IaIF is not attributable to shed Ia determinants, 
due to the inability to absorb out Ia-inducing activity using a standard procedure 
of anti-Ia MAb treatment and protein A-Sepharose column separation used in 
the isolation of Ia glycoprotein species (27). The column released >95% of the 
bound, purified anti-Ia.7 MAb used in the initial absorption step of the experi- 
ment upon elution with 3 M NaSCN (data not shown). 
Discussion 
In this study we describe a series of observations that support the hypothesis 
that  immune interferon (IFN-7)  regulates the expression of macrophage cell 
surface Ia  antigens  by  first  stimulating  the  release  of a  second  macrophage- 
derived factor activity which, in turn, controls the induction of Ia determinant 
expression. Thus we show that after in vitro stimulation by either Con A-activated 
rat  spleen cell supernatant  or cloned murine IFN-~,  the murine macrophage 
tumor  cell  line  P-388D1  releases a  second factor  activity,  Ia-inducing factor 
(IaIF), which will then induce the expression of Ia cell surface determinants on 
the murine monocytic tumor cell line, WEHI-3.  We further demonstrate that 
the P-388D1-derived IaIF activity cannot be blocked by an anti-murine IFN-7 
antiserum, which almost completely blocks the Ia-inducing effect of either cloned 
immune interferon or Con A-activated rat spleen cell supernatant. Additionally, 
we give experimental results that clearly suggest that IaIF activity is not simply 
the effect of shed  Ia  determinants,  since neither the passage  over an  anti-Ia 
affinity column nor treatment of the IaIF supernatant with an excess of anti-Ia 
MAb and subsequent passage  over a  protein  A-Sepharose column specifically 
removed any of the Ia-inducing capacity of the P-388D 1-generated IaIF. 
Since many of the murine B lymphoma and macrophage tumor cells used in 
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shed Ia antigen complexes, the controls used to demonstrate that the IalF activity 
was not due to shed Ia determinants were very critical. It is important to point 
out that  the protein A  column released  >95%  of the purified anti-Ia  7  MAb 
(72a) used in the control experiment upon elution with 3 M NaSCN. Thus there 
was complete binding of the anti-Ia MAb and the lack of significant diminution 
in  Ia-inducing capacity of the anti-Ia.7-treated  IalF after column passage was 
not the result of any abrogation of the normal immunoglobulin-binding prop- 
erties of the protein A  (27). The loss of Ia-inducing activity of the IalF sample 
after passage over the MK-D6 (anti-I-A  a) affinity column was clearly the result 
of nonspecific binding, since loss of activity was observed for both I-A and I-E/ 
C  determinant induction and was observed to occur to a  quantitatively similar 
degree after passage on the negative control (Leu-1) column. In addition to the 
control  experiments  demonstrated  in  this  paper,  there  are  early  studies  by 
Emerson and  Cone  (31,  32)  that  show  that  shed  Ia  antigen  complexes from 
normal  murine  spleen  cells  in  suspension  culture  optimally  attach  to  either 
syngeneic or allogeneic murine T  cells, B cells, or macrophages within 30 min 
(at  37°C),  and are  catabolized by the absorbing cells with a  half-life of ~4  h. 
These observations do not fit the kinetics of Ia induction after IalF treatment 
since Ia expression first appears on WEHI-3 target cells after ~8-12 h and is not 
optimal until 48-72 h in culture (data not shown). 
This report also clearly demonstrates that IalF activity is not due to the release 
of bound exogeneous IFN-7  by the P388.D1  tumor cell line after pulsing the 
macrophage cell line in an induction culture containing cloned IFN-7. Addition- 
ally, IalF activity is not due to P388.Dl-generated  IFN-7,  since the IalF func- 
tional activity cannot be blocked by an anti-IFN-7  heteroantibody and has no 
demonstrable  antiviral  activity.  However,  these  results  do  not  eliminate  the 
theoretical possibility that IalF activity is due to some degradation product of 
IFN-3,  produced  by the  "processing" of IFN-7  by  P388.D1.  This breakdown 
product could conceivably  have  lost  both antiviral  activity and  the  epitope(s) 
recognized  by  the  neutralizing  heteroantiserum,  while  retaining  Ia-inducing 
activity. That this is probably not the case is best demonstrated by the fact that 
we have very recently isolated a  clone of P388.D1  that constitutively releases 
IalF  activity  without any  requirement  for  prior  IFN-7  stimulation  (data  not 
shown). This clone is highly Ia positive and it is our untested hypothesis that the 
constitutive production of IalF activity by such macrophage tumor cell lines and 
possible  normal  cellular  counterparts  may  regulate  the  IFN-3,-independent, 
constitutive expression of Ia antigens by certain macrophage subpopulations. We 
are presently testing this hypothesis. 
Recent experiments by Steeg et al.  (8) and King et al.  (15) offer convincing 
data to support the concept that immune interferon regulates the biosynthesis 
and cell surface expression of Ia antigenic determinants. The experimental data 
described  in  our study confirm the  observations  of these  earlier  experiments 
describing the role of IFN-7 in the regulation of Ia expression and extend our 
knowledge about  the  actual  mechanism whereby  IFN-7  controls  the  positive 
expression of Ia glycoproteins. Based on the experimental evidence offered in 
this report, we argue that immune interferon regulates the biosynthesis and cell 
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possible  biosynthesis)  of an  intermediate  Ia-inducing  factor(s)  (IaIF)  by  the 
macrophages, which subsequently modulate the actual positive induction of Ia 
antigen biosynthesis and expression in the plasma membrane. 
There are well-documented examples of experimental proofs of the general 
concept that the generation of intermediate modulators of cellular activity by 
IFN-3, may be a ubiquitous mechanism whereby this interferon species functions. 
Several  recent papers  (33-35)  show  that  cells treated  with  IFN-~  and  virus- 
induced interferon can transfer viral resistance to cells of the homologous species 
and to cells of a heterologous species insensitive to that interferon. The transfer 
of viral resistance takes place in the complete absence of detectable interferon 
and is dependent upon cell to cell contact. More recently, a study by Lloyd et al. 
(36) determined that co-cultivation of murine L 1210 lymphoblastoid cells with 
human interferon-treated WISH  cells results  in  the transfer of quantitatively 
significant inhibition of proliferation of the murine cell line as measured by [aH]- 
thymidine incorporation. The transfer of antiproliferative activity was not due 
to the carryover of interferon by the interferon-treated cells, and the transfer 
was dependent upon cell to cell contact. Recombinant human IFN-~ and purified 
human IFN-a and IFN-13 all had the same effect. Additional experiments showed 
that murine IFN-stimulated L cells transferred antiproliferative activity to human 
lymphoblastoid Daudi cells. It was once again clearly shown in these experiments 
that there was a  phylogenetic barrier for the direct effect of interferon, since 
neither murine nor human interferon directly induced antiproliferative activity 
in  the heterologous species.  Recently, we have completed preliminary experi- 
ments that suggest that, like the transfer of post-interferon-stimulated antiviral 
or antiproliferative activity, IaIF activity can also be transferred across a species 
barrier.  Thus  neither  purified  human  IFN-~,  nor  conditioned medium from 
U937  induces Ia expression on WEHI-3  target cells, but conditioned medium 
taken from the human macrophage cell line U937 after its activation by a source 
of human IFN-'y induces Ia determinant expression on WEHI-3  cells. Present 
work continues in an effort to confirm these observations. 
Unlike the transfer of post-interferon-activated antiviral or antiproliferative 
activity, the transfer of P-388D1-derived Ia-inductive function is not dependent 
upon cell to cell contact, but is mediated by a  soluble factor released into the 
culture medium. There are several possible reasons for this observation: (a) The 
transfer mechanisms for post-IFN-3,-stimulated  IaIF  activity and antiviral  or 
antiproliferative function may simply be different. (b) Preliminary characteriza- 
tion  analysis  of IaIF  activity  suggests  it  is  extremely hydrophobic  and  that 
supernatant activity is readily lost by dialysis (>200,000  mol wt), passage over 
filtering devices, or simply by storage in glass or plastic containers. If the active 
molecular species responsible for the cell contact-dependent transfer of antiviral 
or antiproliferative function is similarly hydrophobic, it may prove difficult to 
demonstrate its presence. (c) Under normal physiological conditions, the transfer 
of IaIF may be similar to the transfer of antiviral or antiproliferative function, 
and the phenomenon of P-388D1  may simply be an anomaly produced by this 
particular  transformed macrophage cell  line.  In  support  of this  notion  is  the 
observation that, while WEHI-3 is highly inducible for Ia expression by IFN-3,, 
it produces very little soluble IaIF activity by comparison with P-388D1.  Thus, WALKER ET  AL.  1545 
IalF may normally function as an integral component of the cytoplasm or plasma 
membrane  compartments.  (d)  Alternatively,  P-388D1  may represent a  unique 
normal macrophage phenotype in which IaIF is released as a  soluble mediator, 
while other more immature cells of the mononuclear phagocyte lineage may not 
make the factor or may mediate the effects of IaIF via cell to cell contact. All of 
these possibilities are the focus of our present research efforts in this area. 
We presently have  limited  data  concerning  the  biochemical nature  and  the 
physiochemical traits of IaIF, and we are actively engaged in these characteriza- 
tion studies.  Our preliminary  results indicate that  the active material is trypsin • 
sensitive,  has  a  molecular  weight  of ~200,000  as  measured  by gel  filtration 
chromatography using Sephacryi S-300 (Pharmacia Fine Chemicals), and appears 
very hydrophobic (data not shown). The large molecular weight active material 
may represent some aggregated form of the IaIF molecule; more detailed analysis 
is required to fully describe the biochemical/physical properties of IaIF. 
In conclusion, it is important  to point out that the generation and release of 
IaIF  activity  after  IFN-3'  activation  may  represent  an  important  mechanism 
whereby  macrophage,  and  perhaps  other  cells  of the  lymphoid  system  (37) 
amplify the direct effects of IFN-3,  stimulation.  Such a  transducing  molecular 
vector could  potentiate  the  amplified  expansion  of the  number  of Ia-positive 
cells  involved  in  the  modulation  of  immune  responsiveness  after  an  initial 
triggering signal from immune interferon (IFN-3,). 
Summary 
In this report we demonstrate  that when the murine  macrophage tumor cell 
line P-388D1 is incubated for 48-72 h with either concanavalin A-stimulated rat 
spleen cell supernatant  or cloned murine  immune  interferon  (IFN-3,), the cul- 
tured cells release a  cell-free factor activity that in turn  induces the cell surface 
expression of Ia antigen on the murine monocyte cell line WEHI-3. This IFN-3,- 
stimulated,  Ia-inducing activity cannot be blocked with an anti-IFN-3, heteroan- 
tiserum  that  does  block  the  induction  of Ia  expression  on  WEHI-3  by both 
cloned murine IFN-3, and rat Con A  supernatant.  The Ia-inducing factor (IaIF) 
generated from P-388D1  after stimulation by IFN-3, does not demonstrate any 
antiviral  activity.  The  P-388Dl-derived  IaIF is  not shed plasma  membrane  Ia 
glycoprotein molecules, as demonstrated by the inability of the active component 
to bind specifically to an anti-I-A d affinity column or to a protein A column after 
the active supernatant  is first treated with an excess of anti-I-E/C a'k monoclonal 
antibody. 
Received for publication  29 November 1983 and in revised form 24January 1984. 
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